MyMD Pharma Reports US Patent Issued For Co.’s ‘Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases’
MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic